Day: June 28, 2022

DEAPcoin to Be Listed on Huobi Global, One of the Largest Crypto Asset Exchanges

Aiming to further increase the value and utility of DEAPcoin SINGAPORE, June 28, 2022 (GLOBE NEWSWIRE) — Digital Entertainment Asset Pte. Ltd. (DEA), the Singapore-based GameFi platform behind the “PlayMining” ecosystem, revealed its native DEAPcoin (DEP) token will be listed on June 30 11:00 (UTC+8) on “Huobi Global”, one of the world’s leading and largest […]

Read More

Workplace Options acquires Essi Systems’ stress, resiliency and emotional intelligence assessments and behavior change tools to enhance its digital wellbeing solutions offerings

RALEIGH, N.C., June 28, 2022 (GLOBE NEWSWIRE) — Workplace Options, a leading provider of integrated global wellbeing solutions, announced that it acquired Essi Systems’ stress, resiliency and emotional intelligence assessments and behavior change tools. Essi Systems is an international management consulting company that has been delivering scalable human capital solutions to improve employee health and […]

Read More

Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions

The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to patient Yardley, PA, June 28, 2022 (GLOBE NEWSWIRE) — Norstella, an organization that helps life sciences companies navigate the complexities of the drug life cycle, and Citeline (formerly Pharma Intelligence)—a leading provider of specialist intelligence, […]

Read More

Modelo, UFC and Rebuilding Together Launch Year Two of the Gym Revitalization Initiative During 10th Annual UFC International Fight Week

Former UFC Heavyweight Champion Stipe Miocic rejoins Modelo’s community-based initiative to refurbish local gyms and strengthen the Fighting Spirit across the nation Las Vegas Gym Revitalization CHICAGO, June 28, 2022 (GLOBE NEWSWIRE) — As the 10th Annual UFC International Fight Week kicks off, Modelo®, the beer brewed for those with the Fighting Spirit™, and long-standing […]

Read More

ResMed Promotes Lucile Blaise to President, Sleep & Respiratory Care

Lucile Blaise, President, Sleep & Respiratory Care, ResMed Blaise is a medtech industry thought leader with over 25 years’ experience A board member of MedTech Europe since 2020; President of the Snitem, France’s premier medtech association Promotion effective July 1 SAN DIEGO, June 28, 2022 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) today announced […]

Read More

Stromasys Receives Amazon Web Services (AWS) Migration and Modernization Competency

Stromasys CAMBRIDGE, Mass., June 28, 2022 (GLOBE NEWSWIRE) — Stromasys, an industry-leading legacy server emulation company, announced today it had achieved Amazon Web Services (AWS) Migration and Modernization Independent Software Vendor (ISV) Competency status for AWS Partners. This designation recognizes that Stromasys has demonstrated technical proficiency and proven customer success automating and accelerating customer application migration and modernization […]

Read More

Hitachi Energy and Petrofac to collaborate in growing offshore wind market

Collaboration combines complementary technologies and expertise of both companies to increase customer value and help accelerate the energy transition Zurich, Switzerland, June 28, 2022 (GLOBE NEWSWIRE) — Hitachi Energy a market and technology leader in transmission, distribution and grid automation solutions, and Petrofac, a leading international service provider to the energy industry, have entered into […]

Read More

MRM Health Starts Clinical Trial with Next-Generation Optimized Consortium Therapeutic MH002 in Pouchitis

GHENT, Belgium, June 28, 2022 (GLOBE NEWSWIRE) — MRM Health, a clinical-stage biopharmaceutical company developing next-generation live microbiome consortia therapeutics, announced today that they have received regulatory approval from the Federal Agency for Medicines and Health Products (FAMHP) in Belgium to start a Phase 2 trial with the novel next-generation optimized consortium therapy, MH002, in […]

Read More

Recent Posts

Categories